Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis

British Journal of Haematology

Volumn 98, Issue 4, 1997, Pages 1010-1016

  Anderson, Jeanne E ^a,b   Sale, George ^a   Appelbaum, Frederick R ^a   Chauncey, Thomas R ^a   Storb, Rainer ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Agnogenic myeloid metaplasia; Allogeneic transplantation; Essential thrombocytosis; Myelofibrosis; Polycythaemia vera

Indexed keywords

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MYELOFIBROSIS; POLYCYTHEMIA VERA; PRIORITY JOURNAL; THROMBOCYTOSIS; TREATMENT OUTCOME;

EID: 0030756292     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3083125.x     Document Type: Article

References (29)

1. Anderson, J.E., Appelbaum, F.R., Chauncey, T.R. & Storb, R. (1995) Allogeneic bone marrow transplantation (BMT) for polycythemia vera (PV), agnogenic myeloid metaplasia (AMM), and essential thrombocytosis (ET): a series of 13 patients. Blood, 86, (Suppl. 1), 388a (abstract 1540).
2. Banaji, M., Bearman, S.I., Buckner, C.D., Clift, R.A., Bensinger, W.I., Petersen, F.B., Slichter, S.J., McGuffin, R.W., Sanders, J.E., Stewart, P.S., Hill, R.S., Deeg, H.J., Storb, R. & Thomas, E.D. (1986) The effects of splenectomy on engraftment and platelet transfusion requirements in patients with chronic myelogenous leukemia undergoing marrow transplantation. American Journal of Hematology, 22, 275-283.
3. Barosi, G., Ambrosetti, A., Buratti, A., Finelli, C., Liberato, N.L., Quaglini, S., Ricetti, M.M., Visani, G., Tura, S. & Ascari, E. (1993) Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction. Leukemia, 7, 200-206.
4. Berlin, N.I. (1975) Diagnosis and classification of the polycythemias. Seminars in Hematology, 12, 338-351.
5. Budowle, B., Chakraborty, R., Giusti, A.M., Eisenberg, A.J. & Allen, R.C. (1991) Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. American Journal of Human Genetics, 48, 137-144.
6. Clift, R.A., Buckner, C.D., Thomas, E.D., Bensinger, W.I., Bowden, R., Bryant, E., Deeg, H.J., Doney, K.C., Fisher, L.D., Hansen, J.A., Martin, P., McDonald, G.B., Sanders, J.E., Schoch, G., Singer, J., Storb, R., Sullivan, K.M., Witherspoon, R.P. & Appelbaum, F.R. (1994) Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood, 84, 2036-2043.
7. Creemers, G.J., Lowenberg, B. & Hagenbeek, A. (1992) Allogeneic bone marrow transplantation for primary myelofibrosis. British Journal of Haematology, 82, 772-773.
8. Dekmezian, R., Kantarjian, H.M., Keating, M.J., Talpaz, M., McCredie, K.B. & Freireich, E.J. (1987) The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia. Cancer, 59, 1739-1743.
9. de Revel, T., Giraudier, S., Nedellec, G., Joussemet, M., Bourin, P., Schill, H., Gaillard, J.F. & Auzanneau, G. (1995) Allogeneic bone marrow transplantation for postpolycythemic myeloid metaplasia with myelofibrosis: a case report. Bone Marrow Transplantation, 16, 187-189.
10. Dokal, I., Jones, L., Deenmamode, M., Lewis, S.M. & Goldman, J.M. (1989) Allogeneic bone marrow transplantation for primary myelofibrosis. British Journal of Haematology, 71, 158-160.
11. Dupriez, B., Morel, P., Demory, J.L., Lai, J.L., Simon, M., Plantier, I. & Bauters, F. (1996) Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood, 88, 1013-1018.
12. Durnam, D.M., Anders, K.R., Fisher, L., O'Quigley, J., Bryant, E.M. & Thomas, E.D. (1989) Analysis of the origin of marrow cells in BMT recipients using a Y chromosome specific in situ hybridization assay. Blood, 74, 2220-2226.
13. Hoffman, R. & Silverstein, M.N. (1995) Agnogenic myeloid metaplasia. Hematology: Basic Principles and Practice, 2nd edn, pp. 1160-1174.
14. Ifrah, N., Gardembas-Pain, M., Hunault, M., Saint-Andre, J.P., Foussard, C. & Boasson, M. (1989) Allogeneic bone marrow transplantation for primary myelofibrosis. British Journal of Haematology, 73, 575-576.
15. Kalhs, P., Schwansinger, I., Anderson, G., Mori, M., Clift, R.A., Storb, R., Buckner, C.D., Appelbaum, F.R., Hansen, J.A. & Sullivan, K.M. (1995) A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia. Blood, 86, 2028-2032.
16. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457.
17. Murphy, S., Iland, H., Rosenthal, D. & Laszlo, J. (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Seminars in Hematology, 23, 177-182.
18. Rajantie, J., Sale, G.E., Deeg, H.J., Amos, F., Appelbaum, F., Storb, R., Clift, R.A. & Buckner, C.D. (1986) Adverse effect of severe marrow fibrosis on hematologic recovery after chemoradiotherapy and allogeneic bone marrow transplantation. Blood, 67, 1693-1697.
19. Rossbach, H.C., Grana, N.H., Chamizo, W., Barrios, N.J. & Barbosa, J.L. (1996) Successful allogeneic bone marrow transplantation for agnogenic myeloid metaplasia in a 3-year-old boy. Journal of Pediatric Hematology/Oncology, 18, 213-215.
20. Rozman, C., Giralt, M., Feliu, E., Rubio, D. & Cortes, M.T. (1991) Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer, 67, 2658-2663.
21. Scharf, S.J., Smith, A.G., Hansen, J.A., Mcfarland, C. & Erlich, H.A. (1995) Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity. Blood, 85, 1954-1963.
22. Schmitz, N., Suttorp, M., Schlegelberger, B., Weber-Matthiesen, K., Tiemann, M. & Sonnen, R. (1992) The role of the spleen after bone marrow transplantation for primary myelofibrosis. British Journal of Haematology, 81, 616-618.
23. Silverstein, M.N. (1974) Postpolycythemia myeloid metaplasia. Archives of Internal Medicine, 134, 113-115.
24. Singhal, S., Powles, R., Treleaven, J., Pollard, C., Lumley, H. & Mehta, J. (1995) Allogeneic bone marrow transplantation for primary myelofibrosis. Bone Marrow Transplantation, 16, 743-746.
25. Soll, E., Massumoto, C., Clift, R.A., Buckner, C.D., Appelbaum, F.R., Storb, R., Sale, G., Hackman, R. & Martin, P. (1995) Relevance of marrow fibrosis in bone marrow transplantation: a retrospective analysis of engraftment. Blood, 86, 4667-4673.
26. Stobart, K. & Rogers, P.C.J. (1994) Allogeneic bone marrow transplantation for an adolescent with polycythemia vera. Bone Marrow Transplantation, 13, 337-339.
27. Storb, R., Deeg, H.J., Farewell, V., Doney, K., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Hansen, J., Hill, R., Longton, G., Lum, L., Martin, P., McGuffin, R., Sanders, J., Singer, J., Stewart, P., Sullivan, K., Witherspoon, R. & Thomas, E.D. (1986) Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood, 68, 119-125.
28. Witherspoon, R.P., Fisher, L.D., Schoch, G., Martin, P., Sullivan, K.M., Sanders, J., Deeg, H.J., Doney, K., Thomas, D., Storb, R. & Thomas, E.D. (1989) Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. New England Journal of Medicine, 321, 784-789.
29. Yan, X.-Q., Lacey, D., Hill, D., Chen, Y., Fletcher, F., Hawley, R.G. & McNiece, I.K. (1996) A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood, 88, 402-409.